Schizophrenia
-
DNA Methylation, Lateral Ventricular Volume, and Psychiatric Risk for Schizophrenia
In this Papers Podcast, Dr. Charlotte Cecil and Dr. Mannan Luo discusses their co-authored JCPP paper ‘DNA methylation at birth and lateral ventricular volume in childhood: a neuroimaging epigenetics study’.
Read more -
JCPP Editorial: Volume 64, Issue 07, July 2023
Editorial: “What’s in a name? Drawing on the examples of autism and schizophrenia, some reflections on diagnostic labels and their future role in child and adolescent psychiatry” by Angelica Ronald
Read more -
Editorial: What’s in a name? Drawing on the examples of autism and schizophrenia, some reflections on diagnostic labels and their future role in child and adolescent psychiatry
Free Access paper from the JCPP – ‘The diagnostic labels that children and adolescents receive feed into their treatment access and future potential but also to their self-identities. […] the choice of labels used in child and adolescent psychiatry should remain a priority, in light of their impact on translational science, treatment and on individuals, alongside the ever-evolving nature of language itself’. Angelica Ronald (pic)
Read more -
Covid-19’s impact on Loneliness and Mental Health: A Study of Schizotypal Traits and Paranoia
The Covid pandemic lockdown has affected us differently, with some people being impacted more than others. Extensive research has indicated that lockdowns – which broadly include isolation measures, such as, in the UK, being required to stay at home unless for essential reasons – have disproportionately impacted individuals with higher levels of paranoia.
Read more -
Psychosis; Schizophrenia, Hearing Voices, and the Language of ‘Madness’ – recording
Delegates only currently have access to this. This webinar brings together current research, looks at understanding of the concept of psychosis, assessing and managing it, along with exploring the appropriateness of using diagnostic labels and the impact of language in mental healthcare.
Read more -
Polygenic scores for schizophrenia and major depression are associated with psychosocial risk factors in children
Video abstract from Sandra Machlitt-Northen on her JCPP paper ‘Polygenic scores for schizophrenia and major depression are associated with psychosocial risk factors in children: evidence of gene–environment correlation’.
Read more -
Early manifestations of genetic liability for ADHD, autism and schizophrenia at ages 18 and 24 months
Open Access paper from JCPP Advances – “Given that ADHD, autism and schizophrenia are all highly heritable, we tested the hypothesis that in the general population, measures of toddler language development, motor development and temperament are associated with genetic liability to ADHD, autism and/or schizophrenia”. Lucy Riglin (pic) et al.
Read more -
Progressive cortical thinning might identify children at risk of developing psychotic spectrum symptoms
Offspring of patients with schizophrenia or bipolar disorder have an increased risk of developing these conditions. However, our capacity to predict the long-term outcomes of these at-risk individuals is limited. Now, researchers have investigated whether longitudinal changes in brain structure differ in individuals at high familial risk who develop psychotic spectrum symptoms, compared to those who do not and to low-risk controls.
Read more -
Can we prevent psychosis in high-risk adolescents?
Over the past two decades we’ve seen growing efforts to prevent psychosis developing in people with subtle signs and symptoms of the disorder, termed ‘Clinical High-Risk State for Psychosis’ (CHR-P).
Read more -
City living and psychosis: Unpicking an old question using new data
Decades of research point towards a role of urban upbringing in mental health problems, particularly psychosis. Leading theories often refer to the “stress of the city” as a driving factor. Developments in fields spanning geography to genetics call for renewed attention on the topic.
Read more